Difficulty: Medium
Average Score: 69%
Practice
Alveolar type of rhabdomyosarcoma accounts for approximately 1/3 of all cases of pediatric RMS and carries the poorest prognosis. Of the following, the MOST common site of involvement by alveolar type RMS is
Correct answer
C
Rationale
The correct answer is C) extremities. Alveolar type rhabdomyosarcoma (RMS) is an aggressive subtype that commonly affects the extremities in pediatric patients. This site of involvement is associated with a poor prognosis due to the tendency of the tumor to metastasize early and the challenges in achieving complete surgical resection in these areas.
Option A) orbit is less common for alveolar RMS and is more typically associated with embryonal RMS, which has a better prognosis. Option B) middle ear is also less common for alveolar RMS and is often seen in embryonal RMS or alveolar RMS affecting the head and neck region.
Option D) bladder is a site where embryonal RMS commonly occurs, and it is less frequently associated with alveolar RMS. Understanding the typical sites of involvement for different subtypes of RMS is crucial for accurate diagnosis, treatment planning, and prognostication in pediatric patients.
Educationally, this question highlights the importance of recognizing the different subtypes of rhabdomyosarcoma and their typical sites of involvement. It reinforces the need for healthcare providers to have a strong foundation in pediatric oncology to provide optimal care for patients with RMS.
Option A) orbit is less common for alveolar RMS and is more typically associated with embryonal RMS, which has a better prognosis. Option B) middle ear is also less common for alveolar RMS and is often seen in embryonal RMS or alveolar RMS affecting the head and neck region.
Option D) bladder is a site where embryonal RMS commonly occurs, and it is less frequently associated with alveolar RMS. Understanding the typical sites of involvement for different subtypes of RMS is crucial for accurate diagnosis, treatment planning, and prognostication in pediatric patients.
Educationally, this question highlights the importance of recognizing the different subtypes of rhabdomyosarcoma and their typical sites of involvement. It reinforces the need for healthcare providers to have a strong foundation in pediatric oncology to provide optimal care for patients with RMS.